Genetic Genealogy Testing Market to Grow with a CAGR of 7.81% through 2028
Surging demand for DNA testing and high-end investment
for research and development activities is expected to drive the Global Genetic
Genealogy Market growth in the forecast period, 2024-2028.
According to TechSci Research report, “Genetic
Genealogy Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Genetic Genealogy Market
stood at USD 959.39 Million in 2022 and is anticipated to grow with a CAGR of 7.81% in the forecast
period, 2024-2028. The increasing
prevalence of chronic diseases is identified as a major driver during the
forecast period. The ongoing development of pharmacogenomics, which involves
studying genetics and the effects of medication on the human body, is
witnessing a rise to meet the global population's needs.
The growing awareness among consumers about the
advantages of preventive healthcare is contributing to the demand for the
genetic genealogy market in the next five years. Substantial investments by
leading authorities in research and development activities aimed at upgrading
existing infrastructure are significant factors propelling the growth of the
genetic genealogy market.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Genetic Genealogy Market.”
Genetic genealogy plays a crucial role in enhancing
the quality of healthcare services provided to patients, creating lucrative
opportunities for market growth. As the demand for quality healthcare services
continues to rise, the integration of genetic genealogy allows healthcare
facilities to deliver personalized treatments that meet the highest standards
of effectiveness. By leveraging genetic genealogy, healthcare providers can
tailor their services to individual patients, ensuring optimal outcomes and patient
satisfaction. Industry leaders are actively embracing the study of genetic
genealogy to develop innovative products that cater to the unique needs of
patients.
Genetic genealogy serves as a vital tool in the
creation of genealogy data. Genealogy service providers employ various analysis
methods, including oral interviews, genetic genealogy, and family history
information, among others. By collecting DNA samples from individuals, genetic
genealogy enables the study of DNA changes and the gathering of valuable
biological information. The analysis helps uncover ancestral connections and
shed light on the intricate details of one's heritage.
Genetic genealogy offers a multitude of advantages,
thus driving the increasing global demand for its applications. In the realm of
medication, genetic genealogy provides invaluable insights that aid caregivers
and patients in tailoring treatment and medical care to the individual and
their family. Moreover, effective genetic genealogy can offer diagnostic
information, empowering individuals to take necessary medication or treatment.
As the prevalence of cancer and heart diseases continues to rise in Canada,
genetic genealogy becomes even more important in understanding and managing
these conditions. According to the Canadian Cancer Society, cancer accounted
for 28.2% of deaths in Canada, with an estimated 229,200 new cancer cases and
84,600 deaths projected in 2021. However, advancements in treatments such as
biological drugs and chemotherapy are expected to decrease the mortality rate
by 37% in men and 22% in women by 2021.
The growing awareness of cancer development and DNA
mutations among individuals worldwide further emphasizes the significance of
DNA testing. DNA testing allows for the estimation of an individual's
likelihood of developing cancer and provides valuable insights into inherited
cancer susceptibility syndromes. By understanding the patterns of cancer
development, individuals can proactively manage their cancer risks.
Next-generation sequencing (NGS) represents the latest breakthrough in
DNA-testing technology, encompassing whole-exome sequencing and whole-genome
sequencing. NGS enables comprehensive evaluations of individuals with personal
or family history, helping identify genetic markers associated with breast and
ovarian cancer susceptibility. With continuous technological advancements in
genealogy, the market is poised to witness substantial growth with a higher
compound annual growth rate (CAGR).
However, it is important to acknowledge potential
challenges that could impede market growth. Data breaches of historical records
and genealogical data, as well as the negative impact of DNA testing on family
and personal relationships, pose significant concerns. DNA testing results have
the potential to strain relationships within families, as they may reveal risk
statuses and genetic disorders that some family members may not be willing to
confront. The disclosure of such sensitive information can encroach upon
individual autonomy and privacy, necessitating careful consideration of ethical
and privacy implications. By providing detailed insights into ancestry and
genetic predispositions, genetic genealogy continues to revolutionize the
healthcare industry. As the market evolves, striking a balance between
technological advancements and privacy considerations will be crucial to
ensuring the responsible and ethical use of genetic genealogy data.
The Global Genetic Genealogy Market is segmented into test
type, application, end user, regional distribution, and company.
Based on test type, Autosomal DNA testing has emerged
as the dominant method in the genetic testing market in 2022. This is primarily
due to its origin in the nucleus, where it represents an equal contribution of
genetic material from both parents to their offspring. Each individual inherits
50% of their nuclear DNA from their father and 50% from their mother, resulting
in a unique blend of genetic information. This fascinating pattern of inheritance
continues through each generation, leading to approximately 25% of DNA
inherited from each grandparent, 12.5% from each great-grandparent, and so on.
Autosomal DNA testing is of utmost importance when it comes to accurately
estimating a family tree, as it allows us to trace our ancestry through the
diverse genetic contributions of our ancestors.
On the other hand, Y-chromosome DNA testing focuses
exclusively on the paternal line. The Y-chromosome is passed down virtually
unchanged from father to son, creating a direct link between male relatives
across generations. For instance, an individual shares the same Y-DNA as their
father, grandfather, great-grandfather, as well as their paternal uncle and
grandfather's brothers. This type of testing holds significant value in
studying family names and lineage in patrilineal societies. However, it is
important to note that Y-chromosome DNA testing does not provide detailed
information about which specific brother an individual descended from within
the family, as all males within the family share the same Y-DNA. This
limitation underscores the importance of autosomal DNA testing in revealing the
broader genetic diversity and complexity within our family trees.
Based on region, North America segment is expected to
grow during the forecast period. The North America region is anticipated
to dominate the market during the forecast period of 2024-2028. This can be
attributed to the presence of key market players in the region, coupled with a
well-developed healthcare infrastructure, which serves as the primary driver
behind the substantial growth of the genetic genealogy market. Furthermore,
robust economic growth and significant investments by major players have led to
a notable upsurge in market expansion. Additionally, heightened consumer
awareness regarding the advantages of quality treatment, combined with
favorable reimbursement policies for healthcare services, has contributed to
the upward trajectory of market growth.
North America accounted for the largest market share
and is projected to grow during the forecast period. The presence of major
market players in the region, along with a well-developed healthcare
infrastructure, is the main factor responsible for the rapid growth of the
genealogy products and services market. Strong economic growth and substantial
investments by the major players are driving market growth. Consumer awareness
of the benefits of quality treatment, combined with the availability of
attractive reimbursement policies for healthcare services, is contributing to
the market’s growth.
Major companies operating in
Global Genetic Genealogy Market are:
- 23&Me Inc.
- Ancestry.com
- MyHeritage
- Sequencing. Com
- FTDNA
- DNASolves
- Living DNA
- FindmyPast
- Familysearch
- Geneanet
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The global genetic genealogy market is projected to
witness substantial growth during the forecast period. The increasing
prevalence of chronic diseases is a key driving factor in this period. The
ongoing development of pharmacogenomics, which involves the study of genetics
and the impact of medication on the human body, is gaining momentum to meet the
global population's needs. The growing awareness among consumers about the
benefits of preventive healthcare is contributing to the rising demand for the
genetic genealogy market in the next five years. Furthermore, significant
investments by leading authorities in research and development activities to
enhance existing infrastructure are driving the growth of the genetic genealogy
market. Genetic genealogy plays a crucial role in improving the quality of
healthcare services, presenting lucrative opportunities for market growth as
the demand for quality healthcare services remains high. Additionally,
technological advancements in genealogy offer new prospects for the market to
achieve higher growth rates.,” said Mr. Karan Chechi, Research Director with
TechSci Research, a research-based management consulting firm.
“Genetic Genealogy Market Segmented
By Test Type (Autosomal DNA Test, Y- chromosome DNA Test, Mitochondrial DNA
Test), By Application (Heredity & Genetic Disorders, Paternal/Maternal
Lineages, Ancestral Origins, Others), By End User (Direct-to-Consumer Testing
Companies, Law Enforcement Agencies, Research Institutes & Academic
Organizations, Others), By
Region and Competition, Forecast
& Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Genetic Genealogy Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Genetic
Genealogy Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New
York – 10017
Tel:
+1-646-360-1656
Email:
[email protected]
Website:
https://www.techsciresearch.com